Antibiotic Stewardship Related to Delayed Diagnosis and Poor Prognosis of Critically Ill Patients with Vancomycin-Resistant Enterococcal Bacteremia: A Retrospective Cohort Study

References

• Raza T, Ullah SR, Mehmood K, Andleeb S. Vancomycin resistant enterococci: a brief review. J Pak Med Assoc. 2018;68(5):768–772.
   PubMed Web of Science ®Google Scholar
• Arias CA, Murray BE. The rise of the Enterococcus: beyond vancomycin resistance. Nat Rev Microbiol. 2012;10(5):266–278. doi:10.1038/nrmicro2761
   Web of Science ®Google Scholar
• Weiner-Lastinger LM, Abner S, Edwards JR, et al. Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: summary of data reported to the National Healthcare Safety Network, 2015–2017. Infect Control Hosp Epidemiol. 2020;41(1):1–18. doi:10.1017/ice.2019.296
   PubMed Web of Science ®Google Scholar
• Prematunge C, MacDougall C, Johnstone J, et al. VRE and VSE bacteremia outcomes in the era of effective VRE therapy: a systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2015;37(1):26–35. doi:10.1017/ice.2015.228
   Web of Science ®Google Scholar
• National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control. 2004;32(8):470–485. doi:10.1016/j.ajic.2004.10.001
   PubMed Web of Science ®Google Scholar
• Jean SS, Hsueh PR. Antimicrobial drug resistance in Taiwan. J Formos Med Assoc. 2011;110(1):4–13. doi:10.1016/S0929-6646(11)60002-8
   Web of Science ®Google Scholar
• Murray BE, Wood AJJ. Vancomycin-resistant enterococcal infections. N Engl J Med. 2000;342(10):710–721. doi:10.1056/NEJM200003093421007
   PubMed Web of Science ®Google Scholar
• Mundy LM, Sahm DF, Gilmore M. Relationships between enterococcal virulence and antimicrobial resistance. Clin Microbiol Rev. 2000;13(4):513–522. doi:10.1128/CMR.13.4.513
   PubMed Web of Science ®Google Scholar
• Noble WC, Virani Z, Cree RG. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett. 1992;72:195–198. doi:10.1111/j.1574-6968.1992.tb05089.x
   PubMed Web of Science ®Google Scholar
• DiazGranados CA, Zimmer SM, Klein M, Jernigan JA. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis. 2005;41(3):327–333. doi:10.1086/430909
   PubMed Web of Science ®Google Scholar
• Su L-H, Chen IL, Tang Y-F, Lee J-S, Liu J-W. Increased financial burdens and lengths of stay in patients with healthcare-associated infections due to multidrug-resistant bacteria in intensive care units: a propensity-matched case-control study. PLoS One. 2020;15(5):e0233265. doi:10.1371/journal.pone.0233265
   Web of Science ®Google Scholar
• Salgado CD, Farr BM. Outcomes associated with vancomycin-resistant enterococci: a meta-analysis. Infect Control Hosp Epidemiol. 2003;24(9):690–698. doi:10.1086/502271
   PubMed Web of Science ®Google Scholar
• Chou CH, Lee NY, Lee HC, Chang CM, Lee CC, Ko WC. Emergence of vancomycin-resistant Enterococcus bloodstream infections in southern Taiwan. J Microbiol Immunol Infect. 2012;45(3):221–227. doi:10.1016/j.jmii.2011.11.005
   Google Scholar
• Zasowski EJ, Claeys KC, Lagnf AM, Davis SL, Rybak MJ. Time is of the essence: the impact of delayed antibiotic therapy on patient outcomes in hospital-onset enterococcal bloodstream infections. Clin Infect Dis. 2016;62(10):1242–1250. doi:10.1093/cid/ciw110
   PubMed Web of Science ®Google Scholar
• Lautenbach E, Bilker WB, Brennan PJ. Enterococcal bacteremia: risk factors for vancomycin resistance and predictors of mortality. Infect Control Hosp Epidemiol. 1999;20(05):318–323. doi:10.1086/501624
   Web of Science ®Google Scholar
• Furtado GH, Mendes RE, Pignatari AC, Wey SB, Medeiros EA. Risk factors for vancomycin-resistant Enterococcus faecalis bacteremia in hospitalized patients: an analysis of two case-control studies. Am J Infect Control. 2006;34(7):447–451. doi:10.1016/j.ajic.2005.08.015
   Web of Science ®Google Scholar
• Kang Y, Vicente M, Parsad S, et al. Evaluation of risk factors for vancomycin-resistant Enterococcus bacteremia among previously colonized hematopoietic stem cell transplant patients. Transpl Infect Dis. 2013;15(5):466–473. doi:10.1111/tid.12120
   Web of Science ®Google Scholar
• Ghanem G, Hachem R, Jiang Y, Chemaly RF, Raad I. Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients. Infect Control Hosp Epidemiol. 2007;28:1054–1059. doi:10.1086/519932
   PubMed Web of Science ®Google Scholar
• Kaya A, Kaya SY, Balkan II, et al. Risk factors for development of vancomycin-resistant enterococcal bacteremia among VRE colonizers: a retrospective case control study. Wien Klin Wochenschr. 2020;133(9–10):478–483. doi:10.1007/s00508-020-01733-7
   Web of Science ®Google Scholar
• Olivier CN, Blake RK, Steed LL, Salgado CD. Risk of vancomycin-resistant Enterococcus (VRE) bloodstream infection among patients colonized with VRE. Infect Control Hosp Epidemiol. 2008;29:404–409. doi:10.1086/587647
   PubMed Web of Science ®Google Scholar
• Se YB, Chun HJ, Yi HJ, Kim DW, Ko Y, Oh SJ. Incidence and risk factors of infection caused by vancomycin-resistant enterococcus colonization in neurosurgical intensive care unit patients. J Korean Neurosurg Soc. 2009;46(2):123–129. doi:10.3340/jkns.2009.46.2.123
   PubMed Web of Science ®Google Scholar
• Pan S-C, Wang J-T, Chen Y-C, Chang -Y-Y, Chen M-L, Chang S-C. Incidence of and risk factors for infection or colonization of vancomycin-resistant enterococci in patients in the intensive care unit. PLoS One. 2012;7(10):e47297. doi:10.1371/journal.pone.0047297
   PubMed Web of Science ®Google Scholar
• Peel T, Cheng AC, Spelman T, Huysmans M, Spelman D. Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemia. Clin Microbiol Infect. 2012;18(4):388–394. doi:10.1111/j.1469-0691.2011.03591.x
   PubMed Web of Science ®Google Scholar
• Gouliouris T, Warne B, Cartwright EJP, et al. Duration of exposure to multiple antibiotics is associated with increased risk of VRE bacteraemia: a nested case-control study. J Antimicrob Chemother. 2018;73(6):1692–1699. doi:10.1093/jac/dky075
   Web of Science ®Google Scholar
• Johnstone J, Chen C, Rosella L, et al. Patient- and hospital-level predictors of vancomycin-resistant Enterococcus (VRE) bacteremia in Ontario, Canada. Am J Infect Control. 2018;46(11):1266–1271. doi:10.1016/j.ajic.2018.05.003
   Web of Science ®Google Scholar
• Ye JJ, Shie SS, Cheng CW, et al. Clinical characteristics and treatment outcomes of vancomycin-resistant Enterococcus faecium bacteremia. J Microbiol Immunol Infect. 2018;51(6):705–716. doi:10.1016/j.jmii.2017.08.025
   PubMedGoogle Scholar
• Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis. 2011;52(3):285–292. doi:10.1093/cid/cir034
   PubMed Web of Science ®Google Scholar
• Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(1):1–45. doi:10.1086/599376
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi:10.1016/0021-9681(87)90171-8
   PubMedGoogle Scholar
• Knaus WA, Zimmerman JE, Wagner DP, Draper EA, Lawrence DE. APACHE-acute physiology and chronic health evaluation: a physiologically based classification system. Crit Care Med. 1981;9(8):591–597. doi:10.1097/00003246-198108000-00008
   PubMed Web of Science ®Google Scholar
• Lucas GM, Lechtzin N, Puryear DW, Yau LL, Flexner CW, Moore RD. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes. Clin Infect Dis. 1998;26(5):1127–1133. doi:10.1086/520311
   Web of Science ®Google Scholar
• McNeil SA, Malani PN, Chenoweth CE, et al. Vancomycin-resistant enterococcal colonization and infection in liver transplant candidates and recipients: a prospective surveillance study. Clin Infect Dis. 2006;42(2):195–203. doi:10.1086/498903
   PubMed Web of Science ®Google Scholar
• Pujol M, Pena C, Pallares R, Ayats J, Ariza J, Gudiol F. Risk factors for nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis. 1994;13(1):96–102. doi:10.1007/BF02026134
   Web of Science ®Google Scholar
• Rezende NA, Blumberg HM, Ray SM, Metzger BS, Larsen NM, McGowan JE. Risk factors for methicillin-resistance among patients with Staphylococcus aureus bacteremia at the time of hospital admission. Am J Med Sci. 2002;323(3):117–123. doi:10.1097/00000441-200203000-00001
   Web of Science ®Google Scholar
• Katip W, Oberdorfer P. A monocentric retrospective study of AUC/MIC ratio of vancomycin associated with clinical outcomes and nephrotoxicity in patients with enterococcal infections. Pharmaceutics. 2021;13(9):1378. doi:10.3390/pharmaceutics13091378
   PubMed Web of Science ®Google Scholar
• Issaranggoon Na Ayuthaya S, Katip W, Oberdorfer P, Lucksiri A. Correlation of the vancomycin 24-h area under the concentration-time curve (AUC24) and trough serum concentration in children with severe infection: a clinical pharmacokinetic study. Int J Infect Dis. 2020;92:151–159. doi:10.1016/j.ijid.2019.12.036
   PubMed Web of Science ®Google Scholar
• Katip W, Jaruratanasirikul S, Pattharachayakul S, Wongpoowarak W, Jitsurong A, Lucksiri A. The pharmacokinetics of vancomycin during the initial loading dose in patients with septic shock. Infect Drug Resist. 2016;9:253–260. doi:10.2147/IDR.S121513
   PubMed Web of Science ®Google Scholar
• Ferrer R, Martin-Loeches I, Phillips G, et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med. 2014;42(8):1749–1755. doi:10.1097/CCM.0000000000000330
   PubMed Web of Science ®Google Scholar
• Falcone M, Bassetti M, Tiseo G, et al. Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae. Crit Care. 2020;24(1):29. doi:10.1186/s13054-020-2742-9
   PubMed Web of Science ®Google Scholar
• Kim DH, Lee JH, Ha JS, Ryoo NH, Jeon DS, Kim JR. Evaluation of the usefulness of selective chromogenic agar medium (chromID VRE) and multiplex PCR method for the detection of vancomycin-resistant enterococci. Korean J Lab Med. 2010;30(6):631–636. doi:10.3343/kjlm.2010.30.6.631
   Google Scholar
• Seo JY, Kim PW, Lee JH, et al. Evaluation of PCR-based screening for vancomycin-resistant enterococci compared with a chromogenic agar-based culture method. J Med Microbiol. 2011;60(Pt 7):945–949. doi:10.1099/jmm.0.029777-0
   Web of Science ®Google Scholar
• Kang CM, Chen XJ, Chih CC, et al. Rapid identification of bloodstream bacterial and fungal pathogens and their antibiotic resistance determinants from positively flagged blood cultures using the BioFire FilmArray blood culture identification panel. J Microbiol Immunol Infect. 2020;53(6):882–891. doi:10.1016/j.jmii.2020.03.018
   PubMedGoogle Scholar
• Chan WS, Chan TM, Lai TW, et al. Complementary use of MALDI-TOF MS and real-time PCR-melt curve analysis for rapid identification of methicillin-resistant staphylococci and VRE. J Antimicrob Chemother. 2015;70(2):441–447. doi:10.1093/jac/dku411
   Web of Science ®Google Scholar